ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 29 Sept, 13:00 UTC

Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.

science

Sources

• T2ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’BioPharma Dive / Healthcare Dive / MedTech Dive29 Sept, 13:00